Shikimate analogues and methods of use

US2020031791A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020031791-A1
Application numberUS-201916592340-A
CountryUS
Kind codeA1
Filing dateOct 3, 2019
Priority dateFeb 15, 2016
Publication dateJan 30, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure, in at least certain embodiments, is directed to shikimate (shikimic acid) analogues and compositions thereof, devices and kits which contain the shikimate analogues or compositions thereof, and methods of use of the compounds and compositions for treating and neutralizing irritant or odoriferous compounds on animate or inanimate surfaces or in atmospheres. Examples of such irritant and odoriferous compounds include urushiols from poison ivy, oak, and sumac and mercaptans of skunk spray.

First claim

Opening claim text (preview).

What is claimed is: 1 . A composition comprising at least one shikimate analogue, and one or more secondary compounds, the at least one shikimate analogue comprising Structural Formula I or Structural Formula II: wherein, X is O, N, S, or is absent; R 1 is selected from the group consisting of H, (C1-C8)alkyl, (C1-C8)alkenyl, (C1-C8)alkynyl, cyano, halo, nitro, thio, substituted phenyl, phenylmethyl, and substituted naphthalenyl; R 2 is selected from the group consisting of H, (C1-C8)alkyl, (C1-C8)alkenyl, (C1-C8)alkynyl, cyano, halo, nitro, thio, substituted phenyl, phenylmethyl, and substituted naphthalenyl, or is absent; R 3 is selected from the group consisting of fluoro, chloro, bromo, iodo, hydroxyl, substituted phosphate, —O-tosyl, —O-mesyl, (C1-C8)alkoxy, (C2-C8)acyloxy, substituted phenoxy, substituted naphthalenyloxy, substituted naphthalenylmethoxy, (C1-C12)primary amino, (C1-C12)secondary amino, (C1-C12)tertiary amino, and (C1-C12)cyclic amino, (C1-C8)ammonio, (C1-C8)carboxamino, (C1-C8)imino, azido, (C1-C8)azo, cyanato, isocyanato, nitrooxy, cyano, isocyano, nitrosooxy, nitro, nitroso, (C1-C8)substituted carbamoyl, hydroxyamino, morpholino, anilino, indol, pyrrol, imidazole, benzimidazol, pyrazol, guanidino, piperazino, polyamino, and N-methylated polyamino; R 4 is selected from the group consisting of H, (C1-C8)alkyl, (C1-C8)alkenyl, (C1-C8)alkynyl, cyano, halo, nitro, thio, substituted phenyl, hydroxyl, (C1-C8)alkoxy, (C2-C8)acyloxy, (C1-C8)carboxamino, substituted phenoxy, phenylmethoxy, [1-(methoxycarbonyl)ethenyl]oxy, and (1-carboxyethenyl)oxy; R 5 selected from the group consisting of H, (C1-C8)alkyl, (C1-C8)alkenyl, (C1-C8)alkynyl, cyano, halo, nitro, thio, substituted phenyl, hydroxyl, (C1-C8)alkoxy, (C2-C8)acyloxy, (C1-C8)carboxamino, substituted phenoxy, phenylmethoxy, [1-(methoxycarbonyl)ethenyl]oxy, and (1-carboxyethenyl)oxy; and R 6 is selected from the group consisting of H, (C1-C8)alkyl, (C1-C8)alkenyl, (C1-C8)alkynyl, cyano, halo, nitro, thio, substituted phenyl, hydroxyl, (C1-C8)alkoxy, (C2-C8)acyloxy, (C1-C8)carboxamino, substituted phenoxy, phenylmethoxy, [1-(methoxycarbonyl)ethenyl]oxy, and (1-carboxyethenyl)oxy, with the proviso that at least one of the one or more secondary compounds is not water. 2 . The composition of claim 1 , wherein the at least one shikimate analogue has Structural Formula I, wherein X=O, R 1 is (C1-C8)alkyl, R 2 is absent, R 3 is selected from the group consisting of fluoro, chloro, bromo, iodo, and (C1-C8)alkoxy, R 4 =OH, R 5 =OH, and R 6 =OH. 3 . The composition of claim 1 , wherein the at least one shikimate analogue has Structural Formula I, wherein X=O, R 1 =CH 3 , R 2 is absent, R 3 =Cl, R 4 =OH, R 5 =OH, and R 6 =OH (Pericosine A). 4 . The composition of claim 1 , wherein the at least one shikimate analogue has Structural Formula I, wherein X=O, R 1 =CH 3 , R 2 is absent, R 3 =OCH 3 , R 4 =OH, R 5 =OH, and R 6 =OH (Pericosine C). 5 . The composition of claim 1 , wherein the at least one shikimate analogue is selected from the group consisting of Pericosine A, Pericosine B, Pericosine C, and Pericosine D. 6 . The composition of claim 1 , wherein at least one of the one or more secondary compounds is not methanol, ethanol, or a propanol. 7 . The composition of claim 1 , wherein the one or more secondary compounds is selected from the group consisting of organic bases, inorganic bases, and organic/inorganic bases. 8 . The composition of claim 1 , wherein the one or more secondary compounds is an amine or a salt thereof. 9 . The composition of claim 8 , wherein the amine is an alkyl amine. 10 . The composition of claim 9 wherein the alkyl amine is selected from the group consisting of methyl amine, ethyl amine, dimethyl amine, diethyl amine, trimethyl amine, triethyl amine, diethanolamine, triethanolamine, and trimethylammonia. 11 . The composition of claim 8 , wherein the amine is an acyclic or cyclic polyamine. 12 . The composition of claim 11 , wherein the acyclic or cyclic polyamine is selected from the group consisting of spermine, spermidine, tris(2-aminoethyl)amine, cycler, cyclam, 1,4,7-triazacyclononane, 1,1,1-tris(aminomethyl)ethane, ethylenediamine, 1,4-diazabicyclo[2.2.2]octane (DABCO), diethylenetriamine, triethylenetetramine, 1,3-diaminopropane, putrescine, cadaverine, sym-norspermidine, sym-homospermidine, norspermine, thermospermine, carboxyspermidine, norcarboxyspermidine, caldopentamine, caldohexamine, ethylenediamine, 1,2-diaminopropane, 1,3-diaminopropane, N-methylethylenediamine, 1,4-diaminobutane, 3-(methylamino)propylamine, N,N′-dimethylethylenediamine, N-methyl-1,3-diaminopropane, 1-dimethylamino-2-propylamine, 3-(dimethylamino)-1-propylamine, N,N,N′,N′-tetramethyldiaminomethane, N,N,N′-trimethylethylenediamine, N-isopropylethylenediamine, N-propylethylenediamine, 2-(aminomethyl)-2-methyl-1,3-propanediamine, 1,2-diamino-5-bromo-3-chlorobenzene, 3,5-dichloro-1,2-diaminobenzene, 4-bromo-1,2-diaminobenzene, 4,5-dichloro-o-phenylenediamine, 4-chloro-1,3-diaminobenzene, 2-nitro-1,4-phenylenediamine, 3-nitro-1,2-phenylenediamine, 4-nitro-o-phenylenediamine, m-phenylenediamine, o-phenylenediamine, p-phenylenediamine, trans-4-cyclohexene-1,2-diamine, cis-4-cyclohexene-1,2-diamine, hexamethylenetetramine, 4-aminobenzylamine, N,N′-bis(2-aminoethyl)-1,3-propanediamine, methyl 3,4-diaminobenzoate, 1,2-diamino-3,5-dimethylbenzene, 4,5-dimethyl-1,2-phenylenediamine, 4-(2-aminoethyl)aniline, aniline, m-xylylenediamine, phenylethylenediamine, o-xylylenediamine, p-xylylenediamine, 1,8-diaminooctane, N,N-dimethyldipropylenetriamine, 1,2-bis(3-aminopropylamino)ethane, N-tosylethylenediamine, 2,2,4(2,4,4)-trimethyl-1,6-hexanediamine, 1,4-diaminonaphthalene, 1,5-diaminonaphthalene, 1,8-diaminonaphthalene, 4-tert-butyl-2,6-diaminoanisole, 2,2′-oxydianiline, 4,4′-oxydianiline, 3,3′-diaminobenzidine, 3,4′-diaminodiphenylmethane, 4,4′-diaminodiphenylmethane, 4,4′-ethylenedianiline, 2,4,6-triethyl-1,3,5-benzenetrimethanamine, and 1,8-anthracenedimethanamine. 13 . The composition of claim 8 , wherein the amine is selected from the group consisting monoamines, polyamines, or polymeric amines coated on or crosslinked with a polymer particle. 14 . The composition of claim 8 , wherein the amine is selected from the group consisting monoamines, polyamines, or polymeric amines coated on or crosslinked with a polymeric film. 15 . The composition of claim 8 , wherein the amine is selected from the group consisting monoamines, polyamines, or polymeric amines functionalized on or infused into a hydrogel. 16 . The composition of claim 8 , wherein the amine is selected from the group consisting cyclic polyamine homopolymers and heteropolymers comprising at least one of polyvinylamine, polyethyleneimine, polyvicinalamine, polyamidoamine, polyallyamines, and polyetheramines. 17 . The composition of claim 1 , wherein the one or more secondary compounds is a pyridine or pyridinium selected from the group consisting of pyridine, alkylated pyridines, 2,6-lutidine, 2,4-lutidine, pyridazine, pyrimidine, pyrazine, 4-bromopyridine, 2,6-di-tert-butylpyridine, pyridine-2,6-dicarboxylic acid, pyridinium cations, and salts of the above. 18 . The composition of claim 1 , wherein the one or more secondary compounds is an imidazole or alkylated imidazole. 19 . The composition of claim 1 , wherein the one or more secondary compounds is a pyrrole or alkylated pyr

Assignees

Inventors

Classifications

  • with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups · CPC title

  • the ring being unsaturated · CPC title

  • having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

  • having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] in the acid moiety · CPC title

  • Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020031791A1 cover?
The present disclosure, in at least certain embodiments, is directed to shikimate (shikimic acid) analogues and compositions thereof, devices and kits which contain the shikimate analogues or compositions thereof, and methods of use of the compounds and compositions for treating and neutralizing irritant or odoriferous compounds on animate or inanimate surfaces or in atmospheres. Examples of su…
Who is the assignee on this patent?
Univ Oklahoma
What technology area does this patent fall under?
Primary CPC classification C07D303/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).